FIGURE 3 4 Robust synergistic therapy against cancer 4.1 Sensitized chemotherapy As a chemotherapeutic agent, platinum is one of the most widely used metal-based anticancer components (Ghosh, 2019)
Positively charged and metal-doped CQDs show heightened oxidative and inflammatory responses, while negatively charged or hydrophilic CQDs remain generally safe
Award amounts for NSF SBIR/STTR awards will be: Phase I: $305,000 over 6-18 months Phase II: $1,250,000 over 24 months Fast-Track: $1,555,000, with 6-12 months in Phase I and 18-24 months in Phase II NSF will accept Strategic Breakthrough Award proposals for Phase II awardees, upon recommendation by the cognizant Program Officer
Register to Avail the Offer Send OTP By continuing, you agree with our Privacy Policy and Terms and Conditions Hi There, Sign up on PharmEasy now
i od tego czasu jest produkowany syntetycznie jako 15-aminokwasowy fragment biaka znanego jako BPC-157
The animal research is promising, but we are still in early days of understanding how this peptide works in humans
